Search Results - "sodium glucose co-transporter 2 inhibitors"

1

Sodium-glucose co-transporter-2 inhibitors in heart failure and chronic kidney disease: the role of empagliflozin

by M. M. Batyushin
Published 2021-04-01

Subjects: “...sodium-glucose co-transporter-2 inhibitors...”

Get full text

Article

2

Characterization of metabolic parameters in responders and nonresponders treated with canagliflozin monotherapy in drug-naive subjects with Type 2 diabetes

by Eiji Kutoh, Asuka Wada, Teruma Murayama, Jyunka Hayashi
Published 2018-01-01

Subjects: “...sodium-glucose co-transporter 2 inhibitors...”

Get full text

Article

3

Critical Care Management of Diabetic Ketoacidosis Caused by Sodium-Glucose Co-Transporter 2 Inhibitor: A Case Report

by Elif Bombacı, Banu Çevik, Hakan Haydarlar, Kemal Tolga Saracoğlu, Recep Demirhan
Published 2020-10-01

Subjects: “...sodium-glucose co-transporter 2 inhibitors...”

Get full text

Article

4

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?

by Salva R. Yurista, Herman H. W. Silljé, Michiel Rienstra, Rudolf A. de Boer, B. Daan Westenbrink
Published 2020-01-01

Subjects: “...Sodium-glucose co-transporter-2 inhibitors...”

Get full text

Article

5

Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight

by Awadhesh Kumar Singh
Published 2015-01-01

Subjects: “...sodium -glucose co-transporter-2 inhibitors...”

Get full text

Article

6

Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes

by Skelley JW, Carter BS, Roberts MZ
Published 2018-12-01

Subjects: “...sodium-glucose co-transporter 2 inhibitors...”

Get full text

Article

7

ASSESSMENT OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR IN COMBINATION WITH INSULIN ON METABOLIC PARAMETERS AND RENAL MORPHOFUNCTIONAL CHANGES IN RATS WITH EXPERIMENTAL DIABETES MELL...

by D. A. Lebedev, N. P. Likhonosov, Т. P. Tuchina, V. K. Bayrasheva, A. Yu. Babenko
Published 2017-11-01

Subjects: “...sodium-glucose co-transporter 2 inhibitors...”

Get full text

Article

8

Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis

by Walter Masson, Augusto Lavalle-Cobo, Juan Patricio Nogueira
Published 2021-08-01

Subjects: “...sodium–glucose co-transporter-2 inhibitors...”

Get full text

Article

9

Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection

by Adel E. Berbari
Published 2020-12-01

Subjects: “...Sodium-glucose co-transporter 2 inhibitors...”

Get full text

Article

10

Cardiovascular effects of sodium glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus

by Surender Kumar, Pradeep G Talwalkar, Sambit Das, Soumik Goswami
Published 2019-01-01

Subjects: “...sodium glucose co-transporter-2 inhibitors...”

Get full text

Article

11

Sodium-glucose co-transporter 2 inhibitors – a review article

by Marcin Makuch, Marcelina Makuch, Ewa Krzewicka-Romaniuk, Grzegorz Dzida
Published 2019-08-01

Subjects: “...sodium-glucose co-transporter 2 inhibitors...”

Get full text

Article

12

Short-term outcomes of type 2 diabetes mellitus patients treated with canagliflozin in real-world setting

by Manash P Baruah, Sanjay Kalra
Published 2016-01-01

Subjects: “...sodium glucose co-transporter 2 inhibitors...”

Get full text

Article

13

Effect of sodium–glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus

by Aijun Jiang, Zhanrong Feng, Lu Yuan, Ying Zhang, Qian Li, Yuqing She
Published 2021-03-01

Subjects: “...Sodium-glucose co-transporter-2 inhibitors...”

Get full text

Article

14

Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study

by Shih-Chieh Shao, Kai-Cheng Chang, Ming-Jui Hung, Ning-I Yang, Yuk-Ying Chan, Hui-Yu Chen, Yea-Huei Kao Yang, Edward Chia-Cheng Lai
Published 2019-09-01

Subjects: “...Sodium–glucose co-transporter 2 inhibitors...”

Get full text

Article

15

Candidemia Following Ureteric Stent Placement in a Patient With Type 2 Diabetes Treated With Canagliflozin

by Rishi Raj, Jon Hendrie, Aasems Jacob, Derick Adams
Published 2019-01-01

Subjects: “...sodium-glucose co-transporter 2 inhibitors...”

Get full text

Article

16

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus with inadequate glycemic control on metformin: a meta-analysis

by Zhang Jingfan, Li Ling, Liu Cong, Li Ping, Chen Yu

Subjects: “...Sodium-glucose co-transporter 2 inhibitors...”

Get full text

Article

17

The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury

by Chang Chu, Yong-Ping Lu, Lianghong Yin, Berthold Hocher
Published 2019-04-01

Subjects: “...Sodium-glucose co-transporter 2 inhibitors...”

Get full text

Article

18

Sodium-glucose co-transporter-2 inhibitors: A cardiovascular outcome trial analysis

by Viraj Ramesh Suvarna
Published 2021-01-01

Subjects: “...sodium-glucose co-transporter-2 inhibitors...”

Get full text

Article

19

SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease

by Swetha R. Kanduri, Karthik Kovvuru, Panupong Hansrivijit, Charat Thongprayoon, Saraschandra Vallabhajosyula, Aleksandra I. Pivovarova, Api Chewcharat, Vishnu Garla, Juan Medaura, Wisit Cheungpasitporn
Published 2020-08-01

Subjects: “...sodium glucose co-transporter 2 inhibitors...”

Get full text

Article

20

Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center

by Yotsapon Thewjitcharoen, Nalin Yenseung, Areeya Malidaeng, Soontaree Nakasatien, Phawinpon Chotwanvirat, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Thep Himathongkam
Published 2017-12-01

Subjects: “...Sodium-glucose co-transporter 2 inhibitors (SGLT2i)...”

Get full text

Article

Narrow Search